inhaled Nitric Oxide - 30 mcg/kg IBW/hr
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Bellerophon
Overview
inhaled Nitric Oxide - 30 mcg/kg IBW/hr is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
inhaled Nitric Oxide - 30 mcg/kg IBW/hr clinical trials
Explore related
Medical disclaimer. This page summarizes research about inhaled Nitric Oxide - 30 mcg/kg IBW/hr for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.